NCT04071080 is a Phase 1 clinical trial of fluorescein sodium in Urine Sample Authenticity, sponsored by UpTru Inc..

Who is sponsoring NCT04071080?

NCT04071080 is sponsored by UpTru Inc..

What drugs are being tested in NCT04071080?

Interventions in NCT04071080: fluorescein sodium, Placebo.

What condition does NCT04071080 study?

NCT04071080 studies Urine Sample Authenticity.

Is NCT04071080 still recruiting?

NCT04071080 is currently completed. Last updated 6 January 2020.

Last reviewed 2020-01-06 · How we verify

NCT04071080

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples

Completed Phase 1 Last updated 6 January 2020

What this trial tests

Phase 1 trial testing fluorescein sodium in Urine Sample Authenticity in 40 participants. Completed in 28 November 2019.

Timeline

22 August 2019

Primary endpoint
28 November 2019

28 November 2019

Quick facts

Lead sponsor	UpTru Inc.
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	screening
Enrollment	40
Start date	22 August 2019
Primary completion	28 November 2019
Estimated completion	28 November 2019
Sites	1 location across Canada

Drugs / interventions tested

fluorescein sodium — full drug profile →
Placebo

Conditions studied

Urine Sample Authenticity — all drugs for Urine Sample Authenticity →

Sponsor

UpTru Inc.

Who can join

Adults 18 to 55, any sex, with Urine Sample Authenticity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During this study, participants will ingest 100 mg of fluorescein disodium or a placebo (no drug) mixed in GatoradeTM. Participants will then provide a urine sample after 10, 15, 20 or 30 minutes to see if the investigator can detect fluorescein fluorescence (light) in the urine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other UpTru Inc. trials

Trials by the same sponsor.

NCT07356349 — Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04071080 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by UpTru Inc.
Last refreshed: 6 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04071080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing